You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

Certaines de ces informations ou toutes, dans certains cas, n’apparaissent qu’en Anglais. Vous pouvez demander la version française

What’s New in the Drug Formulary

All new and updated drug and regimen monographs, patient information sheets, as well as safety and advice documents added to the Drug Formulary within the last 30 days are available here.

Regimen

Published Date: 15 Aug 2019

Updated
Aug 2019
Regimen

Published Date: 15 Aug 2019

Updated
Aug 2019
Regimen

Published Date: 14 Aug 2019

Revision Summary: added bevacizumab (biosimilar) NDFP form and non-interchangeability description for bevacizumab
Updated
Aug 2019
Drug

Published Date: 14 Aug 2019

Revision Summary: Updated Adverse Effects and Dosing, Emetic Category, Administration and Monitoring sections.
Updated
Aug 2019
Regimen

Published Date: 14 Aug 2019

Revision Summary: Added bevacizumab (biosimilar) NDFP form and non-interchangeability description for bevacizumab
Updated
Aug 2019
Regimen

Published Date: 14 Aug 2019

Revision Summary: added bevacizumab (biosimilar) NDFP form and non-interchangeability description for bevacizumab
Updated
Aug 2019
Regimen

Published Date: 14 Aug 2019

Revision Summary: added bevacizumab (biosimilar) NDFP form and non-interchangeability description for bevacizumab
Updated
Aug 2019
Regimen

Published Date: 14 Aug 2019

Revision Summary: Updated Adverse Effects and Dosing, Administration and Monitoring sections and emetic risk category.
Updated
Aug 2019
Regimen

Published Date: 14 Aug 2019

Revision Summary: added bevacizumab (biosimilar) NDFP form and non-interchangeability description for bevacizumab
Updated
Aug 2019
Regimen

Published Date: 14 Aug 2019

Revision Summary: added bevacizumab (biosimilar) NDFP form and non-interchangeability description for bevacizumab
Updated
Aug 2019
Regimen

Published Date: 14 Aug 2019

Revision Summary: Updated Adverse Effects section, added bevacizumab (biosimilar) NDFP form and non-interchangeability description for bevacizumab
Updated
Aug 2019
Regimen

Published Date: 08 Aug 2019

Updated
Aug 2019